KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Interest Coverage Ratio (2018 - 2026)

Neogenomics filings provide 13 years of Interest Coverage Ratio readings, the most recent being 30.5 for Q1 2026.

  • On a quarterly basis, Interest Coverage Ratio fell 77.37% to 30.5 in Q1 2026 year-over-year; TTM through Mar 2026 was 38.89, a 185.08% decrease, with the full-year FY2025 number at 30.88, down 121.82% from a year prior.
  • Interest Coverage Ratio hit 30.5 in Q1 2026 for Neogenomics, down from 22.39 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 5.06 in Q4 2022 to a low of 284.24 in Q3 2022.
  • Median Interest Coverage Ratio over the past 5 years was 18.14 (2024), compared with a mean of 38.58.
  • Biggest five-year swings in Interest Coverage Ratio: tumbled 827.61% in 2022 and later surged 94.95% in 2023.
  • Neogenomics' Interest Coverage Ratio stood at 5.06 in 2022, then crashed by 118.41% to 11.05 in 2023, then decreased by 2.55% to 11.33 in 2024, then plummeted by 97.64% to 22.39 in 2025, then tumbled by 36.21% to 30.5 in 2026.
  • The last three reported values for Interest Coverage Ratio were 30.5 (Q1 2026), 22.39 (Q4 2025), and 44.8 (Q3 2025) per Business Quant data.